Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

RIPK2

RBC: RIPK2 · Substrate: MBP · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Ponatinib94.50.53
Canertinib87.10.67
Tivozanib82.70.67
Alectinib72.80.65
Erdafitinib72.50.74
Gilteritinib71.10.51
Lazertinib70.40.67
Pacritinib70.20.45
Vandetanib65.40.72
Dabrafenib63.30.63
Gefitinib57.50.65
Dasatinib54.30.70
Dacomitinib52.60.66
Lenvatinib50.40.73
Ibrutinib47.00.72

Known variants

No variants catalogued.
Open in new tab